ロード中...
Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
BACKGROUND: A number of diabetic patients with diabetic neuropathy, in India, were treated with epalrestat, an aldose reductase inhibitor. In this study, more than 2000 patients with diabetic neuropathy, who were treated with epalrestat for 3-12 months, were analyzed to assess the efficacy and the a...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2771994/ https://ncbi.nlm.nih.gov/pubmed/19893679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0972-2327.44558 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|